| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Ray Matthew T. | EVP Chief Lending Officer | 201 5TH AVE SW, OLYMPIA | /s/Kaylene Lahn Attorney in Fact for Matthew Ray | 18 Mar 2026 | 0001961151 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HFWA | Common Stock | Options Exercise | +504 | +2.2% | $24.89* | 23,164 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Options Exercise | +155 | +0.67% | $24.89* | 23,319 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Options Exercise | +662 | +2.8% | $24.89* | 23,981 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Options Exercise | +530 | +2.2% | $24.89* | 24,511 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Options Exercise | +1,664 | +6.8% | $24.89* | 26,175 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Options Exercise | +1,001 | +3.8% | $24.89* | 27,176 | 16 Mar 2026 | Direct | ||
| transaction | HFWA | Common Stock | Tax liability | -749 | -2.8% | $24.89* | 26,427 | 16 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HFWA | Restricted Stock Units | Options Exercise | -504 | -33% | $24.89* | 1,008 | 16 Mar 2026 | Common Stock | 504 | $0.000000 | Direct | F1 | |
| transaction | HFWA | Restricted Stock Units | Options Exercise | -155 | -50% | $24.89* | 155 | 16 Mar 2026 | Common Stock | 155 | $0.000000 | Direct | F2 | |
| transaction | HFWA | Restricted Stock Units | Options Exercise | -662 | -100% | $24.89* | 0 | 16 Mar 2026 | Common Stock | 662 | $0.000000 | Direct | ||
| transaction | HFWA | Restricted Stock Units | Options Exercise | -530 | -12% | $24.89* | 3,714 | 16 Mar 2026 | Common Stock | 530 | $0.000000 | Direct | ||
| transaction | HFWA | Restricted Stock Units | Options Exercise | -1,664 | -50% | $24.89* | 1,664 | 16 Mar 2026 | Common Stock | 1,664 | $0.000000 | Direct | F3, F4 | |
| transaction | HFWA | Restricted Stock Units | Options Exercise | -1,001 | -33% | $24.89* | 2,003 | 16 Mar 2026 | Common Stock | 1,001 | $0.000000 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | RSU award granted 03/01/2018 |
| F2 | RSU award granted 02/22/2022 |
| F3 | RSU Grant February 2024 |
| F4 | Represents award pursuant to 2024 Omnibus Equity Plan; shares vest one third per year over a three year period. Each restricted stock unit represents the right to receive one share of the Issuer's Common Stock upon vesting. |
| F5 | RSU Grant February 2025 |
| F6 | Represents award pursuant to 2023 Omnibus Equity Plan; shares vest one third per year over a three year period. Each restricted stock unit represents the right to receive one share of the Issuer's Common Stock upon vesting. |